ປະເພດຄຳຮ້ອງ
Patent - Foreign
ປະເພດຄຳຮ້ອງຍ່ອຍ
Patent - PCT National Phase
(10) ເລກທີ ແລະ ວັນທີການຈົດທະບຽນ
ສະຖານະ
Abandoned
(180) ມື້ໝົດອາຍຸ
(20) ເລກທີ ແລະ ມື້ ຍື່ນຄຳຮ້ອງ
LA P/738 01.05.2019
(40) ເລກທີ ແລະ ວັນທີເຜີຍແຜ່
(86) ເລກທີ ແລະ ວັນທີ ເອກະສານ PCT
(87) and Date ເລກທີ ແລະ ວັນທີ່ ເຜີຍແຜ່ PCT
(85) ວັນທີເອກະສານເຂົ້າ
(30) ລາຍລະອຽດບຸລິມະສິດ
US 62/668,384
08.05.2018
(51) ການຈັດໝວດໝູ່ IPC
(71/73) ຜູ້ຍື່ນຄຳຮ້ອງ
(72) ຜູ້ປະດິດສ້າງ
(LA) Jennifer L.R, Freeman : 154 Surtees Road, Winston-Salem, North Carolina 27104, United States of America
(LA) Maria Carmen Valcarce Lopez : 1785 Deer Run Ct., Oak Ridge, North Carolina 27310, United Stated of America
(74) ຊຶ່ບໍລິສັດຕົວແທນ
(LA) Lao Trademark Agency : 148-149 Ban Sisavath Kang, Unit 16 Chanthabury District, P.O. Box: 925, Vientiane
(54) ຫົວຂໍ້
(LA) THERAPEUTIC USES OF GLP1R AGONISTS
(57) ບົດສັງເຂບ
(LA)
Methods of using glucagon-like peptide 1 receptor (GLP1R) agonists are generally disclosed herein. In certain aspects, the disclosure provides methods of treating type 2 diabetes that include administering a GLP1R agonist according to certain dosage regimens. In certain other aspects, the disclosure provides methods of treating obesity that include administering a GLP1R agonist according to certain dosage regimens. In certain other aspects, the disclosure provides methods of lowering glycated hemoglobin (for example, lowering HbA1c) that include administering a GLP1R agonist according to certain dosage regimens. Compositions containing GLP1R agonists and their manufacture, for example, for use as a medicament are also disclosed herein.
(58) ການຮຽກຮ້ອງ